Literature DB >> 7477948

Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation.

C Pavlides1, Y Watanabe, A M Magariños, B S McEwen.   

Abstract

Studies were performed in vivo on the dentate gyrus to investigate the possible involvement of Type I and Type II adrenal steroid receptors in the mediation of reported adrenal steroid effects on long-term potentiation, through the use of specific Type I and Type II receptor agonists and antagonists. In adrenalectomized rats, administration of aldosterone, a specific Type I agonist, produced a marked enhancement in long-term potentiation, in comparison to either the adrenalectomized or sham adrenalectomized controls. Administration of RU 28318, a Type I antagonist, which by itself had minimal effects, blocked the aldosterone enhancement. In contrast, administration of the specific Type II agonist, RU 28362, produced a marked decrement in the induction of long-term potentiation. The RU 28362 effect was blocked by a prior injection of the Type II antagonist, RU 38486. Neither adrenalectomy nor administration of any of the steroid agonists or antagonists had noticeable effects on neuronal excitability (as determined by the field potentials), nor on post-tetanic potentiation. These findings are consistent with other studies that have shown a biphasic effect of increasing levels of corticosterone on long-term or prime burst potentiation. Taken together, these studies suggest that Type I receptors, with a high affinity for corticosterone, and Type II receptors, having a lower affinity for corticosterone, form a two-level recognition system to modulate induced synaptic plasticity in opposite directions in the dentate gyrus and possibly also in Ammon's horn.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477948     DOI: 10.1016/0306-4522(95)00151-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  43 in total

Review 1.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Site and time dependent effects of acute stress on hippocampal long-term potentiation in freely behaving rats.

Authors:  Kazuo Yamada; Bruce S McEwen; Constantine Pavlides
Journal:  Exp Brain Res       Date:  2003-07-17       Impact factor: 1.972

Review 3.  Stress and plasticity in the limbic system.

Authors:  Robert M Sapolsky
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

4.  Electrophysiological correlates of neural plasticity compensating for ischemia-induced damage in the hippocampus.

Authors:  Sabrina Wang; Nohjin Kee; Edward Preston; J Martin Wojtowicz
Journal:  Exp Brain Res       Date:  2005-05-10       Impact factor: 1.972

Review 5.  Do stress and long-term potentiation share the same molecular mechanisms?

Authors:  Chiung-Chun Huang; Chih-Hao Yang; Kuei-Sen Hsu
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

6.  Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats.

Authors:  Yantao Zuo; Douglas C Smith; Robert A Jensen
Journal:  Physiol Behav       Date:  2007-01-03

Review 7.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

Authors:  Bruce S McEwen
Journal:  Eur J Pharmacol       Date:  2008-01-30       Impact factor: 4.432

8.  Factors that determine the non-linear amygdala influence on hippocampus-dependent memory.

Authors:  Irit Akirav; Gal Richter-Levin
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

Review 9.  60 YEARS OF NEUROENDOCRINOLOGY: Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation.

Authors:  Bruce S McEwen; Jason D Gray; Carla Nasca
Journal:  J Endocrinol       Date:  2015-05-01       Impact factor: 4.286

10.  Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Authors:  Erick T Tatro; Ian P Everall; Marcus Kaul; Cristian L Achim
Journal:  Brain Res       Date:  2009-06-21       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.